United States Antimony Corp (AMEX:UAMY) does about 3.30M shares in volume on a normal day but saw 2858635 shares change hands in the recent trading day. The company now has a market cap of 400.02M USD. Its current market price is $3.41, marking an increase of 0.29% compared to the previous close of $3.40. The 52 week high reached by this stock is $3.86 whilst the lowest price level in 52 weeks is $0.21.
United States Antimony Corp (UAMY) has a 20-day trading average at $3.07 and the current price is -11.66% off the 52-week high compared with 1523.81% distance from its 52-week low. The 50-day simple moving average of the closing price is $2.29 and its 200-day simple moving average is $1.33. If we look at the stock’s price movements over the week, volatility stands at 8.18%, which increases to 12.42% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 62.79 to suggest the stock is neutral.
The consensus objective for the share price is $4.46, suggesting that the stock has a potential upside of 23.54% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on March 21, 2025 when B. Riley Securities initiated the stock to “Buy” and issued a price target of $3.
The current price level is 11.09%, 49.03%, and 155.57% away from its SMA20, SMA50, and SMA200 respectively, with the UAMY price moving below the 50-day SMA on current market day. United States Antimony Corp (UAMY) stock is up 1.49% over the week and 46.35% over the past month. Its price is 92.66% year-to-date and 1506.22% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at 0.01 and 0.18 for whole year. Expected sales for next quarter are $13.06M, which analysts say will come at $54.25M for the current fiscal year and next year at $110.7M. In addition, estimates put the company’s current quarterly revenue at an average of $8.32M.
To reach the target analysts have set, the stock logically needs to grow 23.54 percent from here.
Outstanding shares total 112.95M with insiders holding 22.92% of the shares and institutional holders owning 18.92% of the company’s common stock. The company has a return on investment of -6.01% and return on equity of -6.39%. The forward price to earnings ratio is 13.82. The beta has a value of 0.19. Price to book ratio is 13.47 and price to sales ratio is 26.78.
